BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen K, Chen L, Ouyang Y, Zhang L, Li X, Li L, Si J, Wang L, Ma K. Pirfenidone attenuates homocysteine‑induced apoptosis by regulating the connexin 43 pathway in H9C2 cells. Int J Mol Med 2020;45:1081-90. [PMID: 32124965 DOI: 10.3892/ijmm.2020.4497] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Seifirad S, Alquran L. Commentary: Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused. Front Med (Lausanne) 2020;7:625440. [PMID: 33585519 DOI: 10.3389/fmed.2020.625440] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 King DR, Sedovy MW, Leng X, Xue J, Lamouille S, Koval M, Isakson BE, Johnstone SR. Mechanisms of Connexin Regulating Peptides. Int J Mol Sci 2021;22:10186. [PMID: 34638526 DOI: 10.3390/ijms221910186] [Reference Citation Analysis]
3 Seifirad S. Pirfenidone: A novel hypothetical treatment for COVID-19. Med Hypotheses 2020;144:110005. [PMID: 32575019 DOI: 10.1016/j.mehy.2020.110005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
4 Cai X, He L, Zhou G, Li S, Liao X. Mogroside IIe Ameliorates Cardiomyopathy by Suppressing Cardiomyocyte Apoptosis in a Type 2 Diabetic Model. Front Pharmacol 2021;12:650193. [PMID: 34012399 DOI: 10.3389/fphar.2021.650193] [Reference Citation Analysis]